Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MENINGOCOCCAL INFECTION”

356 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 356 results

Testing effectiveness (Phase 2)Study completedNCT00262041
What this trial is testing

Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents

Who this might be right for
Prevention of Meningococcal Disease
Novartis Vaccines 524
Testing effectiveness (Phase 2)UnknownNCT02919293
What this trial is testing

Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 360
Post-approval studies (Phase 4)Study completedNCT00581035
What this trial is testing

Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 712
Testing effectiveness (Phase 2)Study completedNCT00126984
What this trial is testing

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 508
Not applicableUnknownNCT05981599
What this trial is testing

Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease

Who this might be right for
Meningococcal Infections
Poitiers University Hospital 100
Large-scale testing (Phase 3)Study completedNCT00384397
What this trial is testing

2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,128
Not applicableStudy completedNCT02398396
What this trial is testing

Investigating Meningococcal Vaccines in Adults

Who this might be right for
Meningococcal VaccinesMeningococcal InfectionsNeisseria Meningitidis+1 more
University of Oxford 15
Very early researchStudy completedNCT03630250
What this trial is testing

Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA)

Who this might be right for
Meningitis, BacterialNeisseria Infection
University of Southampton 35
Testing effectiveness (Phase 2)Study completedNCT01210885
What this trial is testing

Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 495
Post-approval studies (Phase 4)Looking for participantsNCT07252804
What this trial is testing

Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Autoimmune Rheumatologic Disease
University of Sao Paulo General Hospital 263
Post-approval studies (Phase 4)Active Not RecruitingNCT05935176
What this trial is testing

Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 660
Large-scale testing (Phase 3)Active Not RecruitingNCT06446752
What this trial is testing

BIYELA - Bexsero Immunisation in Young Women in Africa

Who this might be right for
GonorrheaGonorrhea of PharynxGonorrhea of Anus+1 more
University of Washington 1,100
Testing effectiveness (Phase 2)Study completedNCT00874549
What this trial is testing

Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Sanofi Pasteur, a Sanofi Company 216
Large-scale testing (Phase 3)UnknownNCT05252715
What this trial is testing

Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months

Who this might be right for
Meningitis, Meningococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,200
Testing effectiveness (Phase 2)Study completedNCT00196976
What this trial is testing

Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 461
Post-approval studies (Phase 4)Study completedNCT00197808
What this trial is testing

Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines

Who this might be right for
Pneumococcal InfectionsMeningococcal Infections
Public Health England 392
Post-approval studies (Phase 4)Study completedNCT02591290
What this trial is testing

Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 60
Large-scale testing (Phase 3)Study completedNCT01717638
What this trial is testing

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 805
Large-scale testing (Phase 3)Study completedNCT01553279
What this trial is testing

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
MCM Vaccines B.V. 284
Large-scale testing (Phase 3)Study completedNCT00326118
What this trial is testing

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 433
Load More Results